Genprex is committed to pay Manhattan Street Capital these fees; Cash of $15k with the option to pay $30k in equity instead of cash. Warrants with face value of $30k priced at the average of the recent ...
RodTurner의 블로그 Genprex is raising capital through their IPO ... Genprex has developed Oncoprex, a unique medicine that is delivered to lung ... system to attack the tumors. Genprex is raising $6.5 mill at a pre-money ...
RodTurner's blog Prospectus. Genprex is raising capital through ... Varner, CEO of Genprex, said, "Had I known the benefits of using Reg A ... treatment to the tumors effectively is a major challenge. Genprex 있다 ...
RodTurner's blog Prospectus. Genprex has completed its S-1 IPO ... Capital has rights to warrants in Genprex, so we have a conflict ... to the tumors effectively is a major challenge. Genprex has developed a unique ...
RodTurner의 블로그 Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16 th- two days left. Their Oncoprex medicine ... cell death. Genprex is raising $6.5 mill at a pre-money valuation ...
S-1 IPO NASDAQ 완료 : GNPX 폐암 임상 단계 유전자 치료
보험업자; Network1 금융 보험업자 변호사; Philip Magri Magri Law LLC, Ft. 플로리다주 로더데일 Genprex 조언; 크리스토퍼 J. 오즈번, Streusand Landon & Ozburn, LLP. 오스틴 TX 양도 대리인; 브이 스톡 ...
부유 한 투자자를위한 비공개 제안
